Inhibition of CTLA-4 induced the upregulation of PD-L1, as well as the activation of the EGFR pathway in NSCLC cells, highlighting a distinct function of CTLA-4 in tumor cells compared to T cells [113]. The gene discussed is EGFR; the disease is neoplasm.